Evidence map›Paper›PMID 40183375›Full record

ArticleGlia2025

The Alzheimer's Disease Gene SORL1 Regulates Lysosome Function in Human Microglia.

Swati Mishra, Nader Morshed, Sonia Beant Sidhu, Chizuru Kinoshita, Beth Stevens, Suman Jayadev, Jessica E Young

Abstract read
In one paragraph

Article in Glia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. The Alzheimer's disease risk gene SORL1 is a regulator of excitatory neuronal function.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Autophagy-lysosomal pathway in neurodegeneration.Molecular neurodegeneration advances · 2026
    Review
  17. Microglial phagocytosis in Alzheimer disease.Nature reviews. Neurology · 2026
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Swati MishraDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
Nader MorshedBoston Children's Hospital, F.M. Kirby Neurobiology Center, Boston, Massachusetts, USA.
Sonia Beant SidhuDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
Chizuru KinoshitaDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
Beth StevensBoston Children's Hospital, F.M. Kirby Neurobiology Center, Boston, Massachusetts, USA.
Suman JayadevInstitute of Stem Cell and Regenerative Medicine, University of Washington, Seattle, Washington, USA.ORCID 0000-0003-3164-9665
Jessica E YoungDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.ORCID 0000-0003-2106-0339

Funding

Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Sakeneh Zraika · 1986 to 2026
$41.4M
University of Washington Alzheimer's Disease Research CenterP30AG066509 · NIA · UNIVERSITY OF WASHINGTON · PI Thomas J. Grabowski · 2020 to 2026
$29.0M
Probing the role of SORL1 and endosomal network genetic variation on Alzheimer's disease phenotypes in human neurons.R01AG062148 · NIA · UNIVERSITY OF WASHINGTON · PI YOUNG, JESSICA ELAINE · 2018 to 2022
$3.2M
Characterization of AD-related endolysosomal dysfunction in human neural cellsR01AG080585 · NIA · UNIVERSITY OF WASHINGTON · PI SUMAN JAYADEV, Jessica E Young · 2024 to 2026
$2.5M
Molecular impact of endolysosomal dysfunction on neuron-glia communication pathwaysF32AG079666 · NIA · BOSTON CHILDREN'S HOSPITAL · PI MORSHED, NADER FRANCIS · 2022 to 2025
$164k
Alzheimer's Association 23AARG-1022491NIA NIH HHS 1F32AG079666-01NIA NIH HHS 5T32AG222-30NIA NIH HHS F32 AG079666NIA NIH HHS P30 AG066509NIA NIH HHS R01 AG062148NIA NIH HHS R01 AG080585NIA NIH HHS R01 AG AG080585NIDDK NIH HHS P30 DK017047
6 · The paper itself

Abstract

The SORL1 gene encodes the sortilin-related receptor protein SORLA, a sorting receptor that regulates endo-lysosomal trafficking of various substrates. Loss of function variants in SORL1 are causative for Alzheimer's disease (AD) and decreased expression of SORLA has been repeatedly observed in human AD brains. SORL1 is highly expressed in the central nervous system, including in microglia, the tissue-resident immune cells of the brain. Loss of SORLA leads to enlarged lysosomes in hiPSC-derived microglia-like cells (hMGLs). However, how SORLA deficiency contributes to lysosomal dysfunction in microglia and how this contributes to AD pathogenesis is not known. In this study, we show that loss of SORLA results in decreased lysosomal degradation and lysosomal enzyme activity due to altered trafficking of lysosomal enzymes in hMGLs. Phagocytic uptake of fibrillar amyloid beta 1-42 and synaptosomes is increased in SORLA-deficient hMGLs, but due to reduced lysosomal degradation, these substrates aberrantly accumulate in lysosomes. An alternative mechanism of lysosome clearance, lysosomal exocytosis, is also impaired in SORL1-deficient microglia, which may contribute to an altered immune response. Overall, these data suggest that SORLA has an important role in the proper trafficking of lysosomal hydrolases in hMGLs, which is critical for microglial function. This further substantiates the microglial endo-lysosomal network as a potential novel pathway through which SORL1 may increase AD risk and contribute to the development of AD. Additionally, our findings may inform the development of novel lysosome and microglia-associated drug targets for AD.

Indexed as

Alzheimer DiseaseLDL-Receptor Related ProteinsLysosomesMembrane Transport ProteinsMicrogliaAmyloid beta-PeptidesCells, CulturedHumansInduced Pluripotent Stem CellsPeptide FragmentsPhagocytosisAmyloid beta-Peptidesamyloid beta-protein (1-42)LDL-Receptor Related ProteinsMembrane Transport ProteinsPeptide FragmentsSORL1 protein, humanAlzheimer's diseasehiPSC‐derived microglialysosomesphagocytosisSORL1

Identifiers

PMID40183375
PMCPMC12121473

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.